Do I need supplements while on GLP-1 medication
Due to tirzepatide's long half-life (approximately five days) and delayed peak concentration (8-72 hours after injection), symptoms typically reflect steady-state effects rather than immediate post-injection peaks
doi: 10.1093/pcp/pch008 54 OtulakK.GarbaczewskaG
The SURMOUNT-1 trial enrolled over 2,500 participants and tested three dose levels against placebo over 72 weeks
When researchers looked at the brains of people with Parkinsons, they discovered that the area that makes dopamine, the substantia nigra, contained as much as 40 percent less glutathione than the rest of the organ
Li S, Liu Z, Joseph P, Hu B, Yin L, Tse LA, et al